Results
eNauka >
Rezultati >
Cost-utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle-income economy setting
| Naziv: | Cost-utility of lifileucel in patients with advanced melanoma after progression on immune checkpoint inhibitors And targeted therapies: a middle-income economy setting | Autori: | Obrenovic, Svetlana; Folic, Marko M   ; Folic, Nevena D ; Jankovic, Slobodan M |
Godina: | 2025 | Publikacija: | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | ISSN: | 0306-5251 British Journal of Clinical Pharmacology Pretraži identifikator |
Tip rezultata: | Naučni članak | DOI: | 10.1002/bcp.70172 | WoS-ID: | 001530850600001 | Scopus-ID: | 2-s2.0-105011212837 | URI: | https://enauka.gov.rs/handle/123456789/991240 | Projekat: | Serbian Ministry of Science, Technological Development and Innovations [175007, 451-03-137/2025-03/200111] | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21M21 - Vodeći međunarodni časopis kategorije M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.